Neha Nanda

Dr. Neha Nanda serves as Clinical Professor of Medicine at the University of Southern California, holding key leadership roles as Hospital Epidemiologist, Medical Director of Antimicrobial Stewardship, and Interim Chief of Infectious Diseases at Keck Medicine of USC. She directs infection prevention programs and emerging infectious disease response across the health system.

Her research centers on infection prevention strategies and emerging pathogens, with emphasis on antimicrobial stewardship, Clostridioides difficile infection, and pandemic response. Recent work explores Long COVID preventive measures, novel fungal diagnostics in transplant patients, and machine learning applications for COVID-19 severity prediction. She advocates for multidisciplinary approaches to reduce healthcare-associated infections through optimized diagnostics and treatment protocols.

Dr. Nanda's publication trends (2019-2025) reveal consistent focus on antimicrobial resistance, diagnostic innovation, and emerging pathogen response. Her work bridges clinical practice with epidemiological research, particularly in transplant infectious diseases and stewardship program implementation.

Her awards include:

• In the Spotlight Award for Ebola Preparedness (Waterbury Hospital, 2015)
• Jonathan Freeman Scholarship (SHEA, 2007)
• William Wirt Winchester Tuberculosis Research Award (Yale, 2007)
• Yale Infectious Diseases Collaborative Fund (2007)

As Medical Director of Antimicrobial Stewardship, she leads multidisciplinary teams developing hospital protocols for infection control. Her pandemic leadership included rapid guideline development for healthcare safety, though specific grant details and student mentoring aren't documented in the source material.

She heads Keck Medicine's Healthcare Epidemiology/Infection Prevention division, managing teams responsible for outbreak response, antimicrobial use optimization, and emerging pathogen preparedness across USC-affiliated hospitals and clinics.